Crossmark Global Holdings’s Chemed CHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $218K | Sell |
468
-405
| -46% | -$170K | ﹤0.01% | 1196 |
|
|
2026
Q1 | $330K | Buy |
873
+383
| +78% | +$164K | ﹤0.01% | 980 |
|
|
2025
Q4 | $210K | Buy |
490
+3
| +0.6% | +$1.31K | ﹤0.01% | 1169 |
|
|
2025
Q3 | $218K | Sell |
487
-665
| -58% | -$301K | ﹤0.01% | 1218 |
|
|
2025
Q2 | $561K | Buy |
1,152
+303
| +36% | +$173K | 0.01% | 839 |
|
|
2025
Q1 | $522K | Buy |
849
+137
| +19% | +$77.9K | 0.01% | 861 |
|
|
2024
Q4 | $377K | Sell |
712
-284
| -29% | -$160K | 0.01% | 954 |
|
|
2024
Q3 | $599K | Sell |
996
-60
| -6% | -$34K | 0.01% | 791 |
|
|
2024
Q2 | $573K | Sell |
1,056
-195
| -16% | -$112K | 0.01% | 763 |
|
|
2024
Q1 | $803K | Sell |
1,251
-26
| -2% | -$15.8K | 0.02% | 684 |
|
|
2023
Q4 | $747K | Sell |
1,277
-133
| -9% | -$74.4K | 0.02% | 693 |
|
|
2023
Q3 | $733K | Sell |
1,410
-77
| -5% | -$40K | 0.02% | 666 |
|
|
2023
Q2 | $778K | Sell |
1,487
-144
| -9% | -$78.7K | 0.02% | 669 |
|
|
2023
Q1 | $877K | Buy |
1,631
+64
| +4% | +$32.6K | 0.02% | 616 |
|
|
2022
Q4 | $800K | Buy |
1,567
+69
| +5% | +$33.6K | 0.02% | 624 |
|
|
2022
Q3 | $654K | Sell |
1,498
-85
| -5% | -$40.9K | 0.02% | 665 |
|
|
2022
Q2 | $743K | Buy |
1,583
+80
| +5% | +$39K | 0.02% | 660 |
|
|
2022
Q1 | $761K | Sell |
1,503
-40
| -3% | -$19.2K | 0.02% | 723 |
|
|
2021
Q4 | $816K | Sell |
1,543
-170
| -10% | -$81.6K | 0.02% | 698 |
|
|
2021
Q3 | $797K | Hold |
1,713
| – | – | 0.02% | 692 |
|
|
2021
Q2 | $813K | Sell |
1,713
-300
| -15% | -$144K | 0.02% | 682 |
|
|
2021
Q1 | $926K | Buy |
2,013
+110
| +6% | +$53.9K | 0.02% | 622 |
|
|
2020
Q4 | $1.01M | Buy |
1,903
+40
| +2% | +$19.7K | 0.03% | 575 |
|
|
2020
Q3 | $895K | Sell |
1,863
-30
| -2% | -$14.7K | 0.03% | 571 |
|
|
2020
Q2 | $854K | Buy |
1,893
+160
| +9% | +$71.4K | 0.02% | 578 |
|
|
2020
Q1 | $751K | Sell |
1,733
-90
| -5% | -$40.2K | 0.03% | 543 |
|
|
2019
Q4 | $801K | Sell |
1,823
-102
| -5% | -$42.9K | 0.02% | 623 |
|
|
2019
Q3 | $804K | Sell |
1,925
-152
| -7% | -$62K | 0.02% | 595 |
|
|
2019
Q2 | $749K | Sell |
2,077
-101
| -5% | -$33.8K | 0.02% | 635 |
|
|
2019
Q1 | $697K | Buy |
2,178
+385
| +21% | +$118K | 0.02% | 663 |
|
|
2018
Q4 | $508K | Sell |
1,793
-756
| -30% | -$228K | 0.02% | 760 |
|
|
2018
Q3 | $815K | Sell |
2,549
-140
| -5% | -$44.6K | 0.02% | 695 |
|
|
2018
Q2 | $865K | Buy |
2,689
+264
| +11% | +$82.6K | 0.02% | 660 |
|
|
2018
Q1 | $662K | Buy |
2,425
+55
| +2% | +$14.6K | 0.02% | 769 |
|
|
2017
Q4 | $576K | Buy |
2,370
+302
| +15% | +$68.6K | 0.01% | 889 |
|
|
2017
Q3 | $418K | Buy |
+2,068
| New | +$407K | 0.01% | 1082 |
|
|
2016
Q3 | $418K | Buy |
+2,068
| New | +$288K | 0.01% | 1082 |
|
Other funds holding CHE
EIP
Crossmark Global Holdings's CHE Position: Q2 2026 in Review
Crossmark Global Holdings reduced its Chemed (CHE) stake by 46% in Q2 2026, selling an estimated $170K and leaving 468 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #1196.
Crossmark Global Holdings first reported a position in CHE in Q3 2016 and has held it in 37 quarters since. The position peaked at $1.01M in Q4 2020. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.
- Crossmark Global Holdings held 468 shares of Chemed worth $218K as of Q2 2026.
- Crossmark Global Holdings sold 405 Chemed shares in Q2 2026, an estimated $170K.
- Chemed made up ﹤0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #1196 holding.
- Crossmark Global Holdings first reported a position in Chemed in Q3 2016 and has held it in 37 quarters since.
- Crossmark Global Holdings's Chemed position peaked at $1.01M in Q4 2020.
- 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.
Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.